Earn the UPMC LGBTQIA+ Affirming Provider designation!

Jul. 2022Important Notices
"UPMC Health Plan has established the LGBTQIA+ Affirming Provider designation to make it easy for members to find providers who can communicate and validate LGBTQIA+ patient experiences and create a safe and welcoming patient-provider relationship for LGBTQIA+ patients. This designation is an indicator of a provider’s cultural competency.

To be eligible for the LGBTQIA+ Affirming Provider designation, providers must be listed in either the UPMC Health Plan Find Care provider directory or the UPMC Health Services Find a Doctor provider directory.

The designation will be visible to patients and members in the directories this summer or fall.

Providers can earn the LGBTQIA+ Affirming Provider designation now by completing three learning modules and an attestation. Each learning module is approved for a maximum of 1.0 AMA PRA Category 1 Credits™.

Non-UPMC employed providers can access the learning modules and attestation on UPMC Health Plan’s patient health resources page.

UPMC-employed providers can access the learning modules and attestation through HR Direct Learning by searching for ""Affirmative Communication with LGBTQIA+ Patients & Members."""

Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates